Carna Biosciences, Inc. (TYO:4572)

Carna Biosciences Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,529	2,108	2,889	3,379	3,817	4,299
Cash & Short-Term Investments	1,529	2,108	2,889	3,379	3,817	4,299
Cash Growth	-51.59%	-27.03%	-14.50%	-11.47%	-11.21%	-12.53%
Receivables	83.27	87	788	182	1,243	129
Inventory	160.85	154	140	118	110	104
Other Current Assets	352.71	388	374	425	148	176
Total Current Assets	2,126	2,737	4,191	4,104	5,318	4,708
Property, Plant & Equipment	-	-	105	100	51	53
Long-Term Investments	46.21	34	51	59	59	70
Other Intangible Assets	-	-	1	1	2	3
Other Long-Term Assets	0	1	1	2	2	1
Total Assets	2,172	2,772	4,349	4,266	5,432	4,835
Accounts Payable	-	2	1	1	2	1
Current Portion of Long-Term Debt	19.99	19	120	151	239	189
Current Portion of Leases	-	8	6	-	-	-
Current Income Taxes Payable	3.48	180	218	265	332	344
Current Unearned Revenue	-	-	-	-	177	169
Other Current Liabilities	127.32	13	30	19	24	24
Total Current Liabilities	150.79	222	375	436	774	727
Long-Term Debt	3.41	8	28	148	300	239
Long-Term Leases	-	24	28	-	-	-
Other Long-Term Liabilities	62.19	44	42	42	45	45
Total Liabilities	216.39	298	473	626	1,119	1,011
Common Stock	2,448	2,447	2,076	1,382	1,056	558
Additional Paid-In Capital	6,199	6,198	5,827	5,133	4,808	4,310
Retained Earnings	-6,753	-6,253	-4,075	-2,922	-1,572	-1,038
Comprehensive Income & Other	62.61	82	48	47	21	-6
Shareholders' Equity	1,956	2,474	3,876	3,640	4,313	3,824
Total Liabilities & Equity	2,172	2,772	4,349	4,266	5,432	4,835
Total Debt	23.4	59	182	299	539	428
Net Cash (Debt)	1,506	2,049	2,707	3,080	3,278	3,871
Net Cash Growth	-50.48%	-24.31%	-12.11%	-6.04%	-15.32%	-7.57%
Net Cash Per Share	81.85	114.41	161.13	226.18	258.20	314.74
Filing Date Shares Outstanding	19.1	19.1	17.14	16.34	13.48	12.4
Total Common Shares Outstanding	19.1	19.1	17.14	14.21	13.31	12.4
Working Capital	1,975	2,515	3,816	3,668	4,544	3,981
Book Value Per Share	102.43	129.55	226.07	256.14	324.08	308.34
Tangible Book Value	1,956	2,474	3,875	3,639	4,311	3,821
Tangible Book Value Per Share	102.43	129.55	226.02	256.07	323.93	308.10
Order Backlog	-	13.09	39.76	58.12	257.29	214.93

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.